UPDATE 1-FDA approves AbbVie's new rheumatoid arthritis drug
August 16, 2019 at 12:49 PM EDT
The U.S. Food and Drug Administration on Friday approved AbbVie Inc's new treatment for rheumatoid arthritis, a win for the drugmaker seeking to widen its portfolio as its blockbuster flagship therapy Humira faces competition.
